| 期刊簡介 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Biochemistry and Biophysics Reports (According to the latest JCR data, this journal is not indexed in the JCR.) LetPub Score 4.4
50 ratings
Rate
Reputation 4.9 Influence 3.0 Speed 9.3 | ||||||||||||||||||||||||
| 期刊簡稱 | |||||||||||||||||||||||||
| ISSN | 2405-5808 | ||||||||||||||||||||||||
| h-index | N.A. | ||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||
| 自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||||||
| 官方網站 | http://www.journals.elsevier.com/biochemistry-and-biophysics-reports/ | ||||||||||||||||||||||||
| 在線稿件提交 | |||||||||||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||||||||||
| 出版商 | Elsevier | ||||||||||||||||||||||||
| 主題領域 | Biochemistry, Genetics and Molecular Biology | ||||||||||||||||||||||||
| 出版國/地區 | Netherlands | ||||||||||||||||||||||||
| 發行頻率 | |||||||||||||||||||||||||
| 創刊年 | 0 | ||||||||||||||||||||||||
| 每年文章數 | 198每年文章數趨勢 | ||||||||||||||||||||||||
| 黃金OA百分比 | 94.09% | ||||||||||||||||||||||||
OA Related Info | APC: Yes（ USD2210; ） APC waiver：Check Notes Other charges: No Keywords: biochemistry、biophysics、molecular biology、cell biology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q3
| ||||||||||||||||||||||||
| 索引 (SCI or SCIE) | |||||||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2405-5808%5BISSN%5D | ||||||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 8 Weeks | ||||||||||||||||||||||||
| 競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||||||
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Biochemistry and Biophysics Reports] 的評論 | 撰寫評論 |
| 作者: Hugogo 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-07-24 09:37:54 評論於 Children are similar to BBRC and have the opportunity to go to the fourth district.  (0) 讚！ | Hugogo  |
| 作者: lanlanwater 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-07-08 13:45:12 評論於 Let me check. This year, all ESCI (Emerging Sources Citation Index) have an impact factor, but they are not SCI (Science Citation Index). Even if you submit, it will be in vain. (0) 讚！ | lanlanwater |
| 作者: lanlanwater 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-07-08 13:42:58 評論於 JCR did not get in, so the Chinese Academy of Sciences definitely didn't, and it hasn't been included in SCI either. (0) 讚！ | lanlanwater |
| 作者: Bazinga5 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-07-07 17:08:10 評論於 Received 22 April 2023; Received in revised form 8 June 2023; Accepted 24 June 2023 Pure bioinformatics analysis, transferred journal, overall speed is acceptable. The editor mentioned during the transfer that the journal will receive its first impact factor in June this year, which is why I took the risk to submit. At that time, I checked and the immediate impact factor was around 2.5, which seemed decent. The results came out at the end of June, and it was 2.7, as expected. Now I hope that by the end of the year, it can be ranked as a 4th tier in the Chinese Academy of Sciences, and of course, even better if it is ranked as 3rd tier. For those who are eager to graduate, this newly obtained impact factor journal is worth a try. (0) 讚！ | Bazinga5 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
